Identification | Back Directory | [Name]
1,N6-Etheno-9-(beta-D-xylofuranosyl)adenosine | [CAS]
2095417-39-1 | [Synonyms]
1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine 1,N6-Etheno-9-(b-D-xylofuranosyl)adenosine 1,N6-Etheno-9-(beta-D-xylofuranosyl)adenosine | [Molecular Formula]
C12H13N5O4 | [MOL File]
2095417-39-1.mol | [Molecular Weight]
291.26 |
Hazard Information | Back Directory | [Uses]
1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|